Analyst Price Targets — OM
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 12, 2026 12:28 pm | Marie Thibault | BTIG | $15.00 | $4.54 | TheFly | Outset Medical price target lowered to $15 from $17 at BTIG |
| January 7, 2026 12:35 pm | Rick Wise | Stifel Nicolaus | $8.00 | $4.29 | TheFly | Outset Medical price target lowered to $8 from $14 at Stifel |
| December 17, 2025 1:50 pm | Shagun Singh | RBC Capital | $7.00 | $4.02 | TheFly | Outset Medical price target lowered to $7 from $17 at RBC Capital |
| November 11, 2025 9:57 am | Rick Wise | Stifel Nicolaus | $14.00 | $12.07 | StreetInsider | Outset Medical Inc. (OM) PT Lowered to $14 at Stifel |
| July 14, 2025 11:31 am | Marie Thibault | BTIG | $37.00 | $19.92 | TheFly | Outset Medical price target lowered to $37 from $45 at BTIG |
| March 21, 2025 6:49 pm | Rick Wise | Stifel Nicolaus | $15.00 | $10.05 | TheFly | Outset Medical price target adjusted to $15 at Stifel after reverse stock split |
| August 8, 2024 3:56 am | Shagun Singh | RBC Capital | $3.00 | $3.40 | StreetInsider | RBC Capital Downgrades Outset Medical Inc. (OM) to Sector Perform |
| June 21, 2024 6:20 am | Shagun Singh | RBC Capital | $6.00 | $3.59 | TheFly | Outset Medical upgraded to Outperform at RBC on expected return to growth |
| April 17, 2024 10:55 am | Rick Wise | Stifel Nicolaus | $6.00 | $2.27 | StreetInsider | Stifel on Outset Medical Inc. (OM): 'we expect this home hemodialysis agreement will be a positive incremental sales driver in 2025 and beyond' |
| April 8, 2024 6:12 am | Maria Thibault | BTIG | $6.00 | $2.05 | StreetInsider | BTIG Starts Outset Medical Inc. (OM) at Buy |
Latest News for OM
SAN FRANCISCO, July 6, 2026 /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP advises Outset Medical, Inc. (NASDAQ: OM) investors that the firm is investigating potential legal claims arising from alleged false statements about FDA clearance requirements for one of the company's key products and demand for its dialysis machines. Current shareholders are encouraged to contact the firm here:…
SAN JOSE, Calif., July 02, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity (the “Company”), today announced that the Compensation Committee of its Board of Directors approved equity awards under the Company's Inducement Plan, as a material inducement to employment…
Outset Medical (OM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
GENEVA--(BUSINESS WIRE)--OM Pharma Unveils the Largest Multi-Country Real-World Evidence Study on Broncho Vaxom® (OM 85) for RTI Prevention at EAACI 2026.
MONTREAL, June 09, 2026 (GLOBE NEWSWIRE) -- Osisko Metals Incorporated (the "Company" or "Osisko Metals") ( TSX: OM ; OTCQX: OMZNF ; FRANKFURT: 0B51 ) is pleased to announce initial results from the 2026 drill program at the Gaspé Copper Project, located in the Gaspé Peninsula of Eastern Québec. Five drills are currently active on the property, with two additional drills commencing work this month.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for OM.
U.S. House Trading
No House trades found for OM.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.